Home › Mesothelioma › Virginia › Arlington
Mesothelioma clinical trials in Arlington, VA
6 studies for Mesothelioma are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi away
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- Next Oncology Virginia, Fairfax · 11 mi away
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecruitingPhase 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi away
A 2-part Phase 1/2 Open-label Trial on ODM-212
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
RecruitingPhase 1/2
- Virginia Cancer Specialists, PC, Arlington
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Washington, DC9 studies
- Chicago, IL9 studies
- Nashville, TN8 studies
- Boston, MA8 studies
- Philadelphia, PA6 studies
- Pittsburgh, PA6 studies
- Seattle, WA6 studies
- Los Angeles, CA6 studies
- Rochester, MN5 studies
- Columbus, OH5 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer46 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.